Original Research
Published on 29 Oct 2020
Dual Tracers of 16α-[18F]fluoro-17β-Estradiol and [18F]fluorodeoxyglucose for Prediction of Progression-Free Survival After Fulvestrant Therapy in Patients With HR+/HER2- Metastatic Breast Cancer
in Cancer Imaging and Image-directed Interventions
Frontiers in Oncology
doi 10.3389/fonc.2020.580277
- 6,189 views
- 21 citations
![Dual Tracers of 16α-[18F]fluoro-17β-Estradiol and [18F]fluorodeoxyglucose for Prediction of Progression-Free Survival After Fulvestrant Therapy in Patients With HR+/HER2- Metastatic Breast Cancer](https://www.frontiersin.org/files/myhome article library/580277/580277_Thumb_400.jpg)